N atural killer cell cytotoxicity is under negative control by inhibitory receptors, such as human killer cell Ig-like receptors (KIRs) specific for HLA-B and HLA-C, and CD94-NKG2A, which binds to HLA-E (1). Upon binding to MHC class I on target cells, inhibitory receptors become phosphorylated on tyrosine residues within ITIMs and recruit the tyrosine phosphatase SH2-containing protein tyrosine phosphatase-1 (SHP-1) to terminate NK cell activation signals at a very proximal step (1) . Dephosphorylation of the guanine nucleotide exchange factor Vav1 by SHP-1 during KIR-mediated inhibition may be sufficient to block NK cell cytotoxicity (1, 2) , as Vav1 is essential for actindependent receptor clustering, immune synapse formation, and for signaling by the NK cell activation receptor NKG2D-DAP10 (3, 4) .
Polarized fusion with the plasma membrane of lytic granules containing granzymes and perforin is required for Fas ligandindependent CTL and NK cell cytotoxicity (5, 6) . Signals for granule polarization and degranulation can be uncoupled in NK cells (7) . Expression of ICAM-1, a ligand of b 2 integrin LFA-1, on Drosophila cells was sufficient to induce polarization of granules but not degranulation. Conversely, engagement of the IgG Fc receptor CD16 by rabbit IgG on Drosophila cells induced degranulation without specific polarization (7) . A question raised by these findings is whether inhibitory receptors block a proximal step in a common signaling pathway upstream of polarization and degranulation, thereby blocking both, or selectively inhibit one of those two processes. Selective inhibition of either polarization or degranulation would be sufficient to protect a target cell from lysis by NK cells. Inhibition of granule polarization in KIR + NK cell clones by HLA-C on target cells has been reported (8) . However, it is not clear if the inhibitory receptor-HLA class I interaction is sufficient to confer inhibition, independently of the many other receptor-ligand interactions that occur during NK cell-target cell contact. The Drosophila cell line S2 transfected with various ligands of human NK cell receptors, including HLA class I ligands of inhibitory receptors, is a system well suited to address these questions (9) (10) (11) . Here we show that granule polarization is highly sensitive to inhibition, whereas degranulation has more complex requirements for inhibition.
Materials and Methods

Cells and Abs
Human NK cells were isolated and cloned as described (12) and screened for expression of CD158a, CD158b, and CD159a by flow cytometry. The HLA class I-negative cell line 721.221 (13) , referred to as 221 cells, and 221-Cw3, 221-Cw15, and 221-E (0.221-AEH, a gift of D. Geraghty, Fred Hutchinson Cancer Research Center, Seattle, WA) cells were cultured as described (14) . Drosophila S2 cells were transfected with the insect expression vector pAc5.1 (Invitrogen, Carlsbad, CA) along with the vector pNeofly as described (15) . Full-length lectin-like transcript 1 (LLT1) cDNA in pAc5.1 was a gift of Y. Bryceson (Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD). HLA class I on S2 cells were loaded with specific peptides (GAVDPLLAL for HLA-Cw3, QYDDAVYKL for HLA-Cw4, and VMAPRTLIL for HLA-E). Abs used were CD158a (EB6), CD158b (GL183), and CD159a (Z199) (Immunotech, Beckman Coulter, Miami, FL) for screening of NK clones, rabbit anti-S2 cell serum for stimulation through CD16 (7), anti-perforin for detecting perforin polarization (7), mAb F4/326 (anti-HLA-C; a gift of S.Y. Yang, Histogenetics, New York, NY), anti-HLA-E mAbs MEM-E/06 and MEM-E/07 (Exbio Antibodies, Vestec, Czech Republic), anti-CD54 (BD Pharmingen, San Diego, CA), anti-ULBP1 (R&D Systems, Minneapolis, MN), and anti-flag Ab, M2 (Sigma Aldrich, St. Louis, MO), for detecting expression of flag-tagged LLT1. To engage CD16 on NK cells, S2 cells were incubated with rabbit anti-S2 cell serum at a 1 3 10 24 dilution (unless indicated otherwise), and 221 cells were incubated with anti-HLA-DR IgG2a mAb L243 at 1 mg/ml. scribed (7) . Conjugates with polarized perforin were scored visually from three-dimensional confocal z-stacks. Perforin-containing granules were considered polarized when most of the fluorescence was concentrated in the lower quadrant of the NK cell (i.e., the quadrant that is closest to the target cell). The distinction between polarized and unpolarized granules was obvious in most cases. ELISPOT assays were set up to count the number of NK cells that secreted granzyme B (GrzB) above a set threshold level, as described (16) . Effector and target cell suspensions were applied in triplicate at a 1:1 ratio and incubated at 37˚C for 3 h. Spots were enumerated with an ELISPOT plate reader (CTL Immunospot, Shaker Heights, OH). The number of ELISPOTs obtained with NK cells alone was subtracted from the experimental values. Cells (2 3 10 5 NK and target cells; 1:1) were incubated overnight at 37˚C. MIP-1a released was determined by ELISA (R&D Systems).
Results
Inhibitory receptors for HLA-C and HLA-E block granule polarization and granzyme release induced by 721.221 cells A large panel of NK cell clones was assembled from peripheral blood of several individuals. To test for inhibition through KIR or CD94-NKG2A receptors, the HLA class I-negative human cell line 721.221 (referred to as 221 cells) transfected with HLA-Cw3 (221-Cw3), HLA-Cw15 (221-Cw15), or HLA-E (221-E) was used (Fig.  1A) . HLA-Cw3 is a ligand for the CD158b inhibitory receptors KIR2DL2 and KIR2DL3. HLA-Cw15 is a ligand for the CD158a inhibitory receptor KIR2DL1. HLA-E is a ligand for the inhibitory receptor CD94-NKG2A. The inhibitory function of receptors on NK cell clones was first established in cytotoxicity assays with transfected 221 cells (Fig. 1B) . This was necessary because most Abs do not distinguish between inhibitory KIR2DL1 (CD158a) and activating KIR2DS1 (CD158h) or between inhibitory KIR2DL2/3 (CD158b) and activating KIR2DS2 (CD158j). Also, HLA-E binds to both inhibitory CD94-NKG2A and activating CD94-NKG2C receptors. A typical lysis assay with a clone coexpressing CD158b and NKG2A is shown in Fig. 1B . The observed inhibition of lysis with 221-Cw3 and 221-E but not 221-Cw15 cells indicated that this particular NK clone expressed inhibitory CD158b and NKG2A, consistent with GL183 and Z199 mAb staining (not shown). Every NK clone used in this study underwent such functional screening for expression of inhibitory receptors.
To test whether inhibitory receptors can block granule polarization, conjugates of NK cell clones with 221-Cw3 and 221-E cells were fixed, stained for intracellular perforin, and analyzed by threedimensional imaging of confocal z-stacks. Perforin-containing granules in a CD158a -b + NKG2A + NK clone polarized toward 221 target cells but not when mixed with either 221-Cw3 or 221-E resistant cells (Fig. 1C, 1D ). As control, polarization was scored for NK cells in contact with the insect cell line S2 (Fig. 1D) . In this and in many other experiments, granules appeared to be polarized toward S2 cells in 20-30% of NK cell contacts. As granules are often polarized to one side of NK cells, independently of any particular stimulus, one would expect random contacts with S2 cells to give the appearance of polarization in a fair proportion of NK cells. Nevertheless, the distinction between active granule polarization (.60% of conjugates) and inhibition of granule polarization (apparent polarization in 20-30% of conjugates, which is equivalent to the S2 cell control) was always clear. Inhibition of granule polarization was also observed with other NK clones and with the cell line NK92 transfected with inhibitory receptor KIR2DL1 (data not shown). Therefore, we conclude that inhibitory signals delivered by KIR and by CD94-NKG2A block the movement of lytic granules toward the NK cell immunological synapse.
To determine whether inhibition of target cell lysis was also achieved by a block in the fusion of lytic granules with the plasma membrane, a degranulation assay was developed. The release of GrzB by NK clones was measured by an ELISPOT assay. A large panel of NK cell clones expressing either CD158a, CD158b, or both were tested for their ability to release GrzB during mixing with either 221 cells, 221-Cw3 cells, or 221-Cw15 cells ( Fig. 2A) . The data are presented as the number of ELISPOTs relative to the number of spots obtained with 221 cells (i.e., in the absence of inhibition), and each data point represents a different NK clone. Degranulation was clearly inhibited whenever a specific KIR-HLA-C receptor-ligand combination was present, although the extent of inhibition varied among clones that shared a KIR phenotype. In addition, partial but significant inhibition was observed with CD158a -b + clones mixed with 221-Cw15 cells (p = 0.006), consistent with the reported cross-reactivity of KIR2DL2 with group 2 HLA-C allotypes, such as HLA-Cw15 (17, 18) . This crossreactivity is also consistent with the more complete inhibition of double-positive CD158a + b + clones by 221-Cw15 cells compared with inhibition of CD158a + b -clones (p = 0.02). The ability of NKG2A to inhibit GrzB release was tested using 221-E target cells (Fig. 2B) . Inhibition was observed with every clone expressing NKG2A. Individual variability in the extent of inhibition was again observed among different clones. NK cell clones that do not express CD94-NKG2A are uncommon. Only four such clones were tested. As expected, no inhibition with 221-E target cells was observed (Fig. 2B) . Therefore, engagement of inhibitory receptors by HLA class I on 221 cells resulted in inhibition of both granule polarization and GrzB release. + NK clone conjugated with 221, 221-Cw3, or 221-E cells and stained for perforin with an mAb followed by an Alexa 488-conjugated goat anti-mouse IgG Ab. D, Polarization was scored as polarized (black) and nonpolarized (white). NK cells in contact with Drosophila S2 cells served as control. The number (n) of conjugates scored is listed.
GrzB and MIP-1a release induced by CD16 is not blocked by inhibitory receptor ligands on insect cells
It is not known how the many receptor-ligand interactions that occur during NK-221 cell contact contribute to the inhibition mediated by HLA class I-specific inhibitory receptors. To address this question, we used the Drosophila cell line S2 transfected with ligands of human NK cell receptors, including HLA class I ligands of inhibitory receptors. Stimulation through CD16 was achieved using a rabbit antiserum to S2 cells. Furthermore, S2 cells can be used to separate signals for polarization, through LFA-1, from signals for degranulation, through CD16 (7). Addition of increasing amounts of rabbit antiserum to S2 cells resulted in a small increase of GrzB release, relative to the level of GrzB released spontaneously by IL-2-activated NK cells (Fig. 3A) . However, GrzB release was strongly increased when rabbit antiserum was added to S2 cells expressing ICAM-1 (S2-ICAM-1). Half-maximal GrzB release occurred at an ∼1 3 10 25 dilution of anti-S2 rabbit antiserum (Fig. 3A) . Engagement of CD16 by rabbit IgG on S2 cells resulted also in the release of MIP-1a (Fig. 3B) . Unlike GrzB release, MIP-1a secretion did not show a pronounced dependence on ICAM-1. MIP-1a release assays were preferred over IFN-g and TNF-a secretion because IL-2-activated NK cells release a high basal level of IFN-g and TNF-a.
To test for inhibition of GrzB and MIP-1a release, S2 cells were cotransfected with ICAM-1, b 2 -microglobulin, and either HLACw3 (S2-ICAM-1+Cw3 cells) or HLA-E (S2-ICAM-1+E cells) (Fig. 4A ). These cells were either loaded or not loaded with peptides that bound specifically to either HLA-Cw3 or HLA-E to test for inhibition of GrzB and MIP-1a release. As class I is transported "empty" to the surface of Drosophila cells, it cannot be recognized by inhibitory receptors unless loaded with exogenous peptide (10, 19) . The inhibition induced by HLA class I on S2 cells was tested using the same cells, either before or after loading with specific peptides. With this approach, S2 cells provide a more rigorous test of HLA class I-dependent inhibition than that by use of independent transfected cells that do or do not express an HLA ligand for inhibitory receptors.
In a panel of 23 NK clones that expressed inhibitory CD158b, most of the clones showed no inhibition of GrzB release during mixing with S2-ICAM-1+Cw3 cells that had been loaded with an HLA-Cw3-specific peptide and incubated with rabbit antiserum at a dilution of 1 3 10 24 (Fig. 4B) . Partial inhibition, which was beyond the SD, was observed with only three clones. More pronounced but still partial inhibition was observed with CD94-NKG2A + NK cells during incubation with S2-ICAM-1+E cells loaded with an HLA-E-specific peptide ( The number of GrzB ELISPOTs obtained was 675 6 81 with 221, 117 6 50 with S2-ICAM-1, and 553 6 62 with S2-ICAM-1+IgG. Therefore, stimulation of GrzB release was not greater with S2-ICAM-1+IgG Fc than with 221 cells. We also tested whether peptide-loaded HLA-Cw3 on S2 cells would inhibit weaker CD16 activation signals by measuring inhibition over a broad range of anti-S2 cell serum concentrations. No inhibition of degranulation was observed at any of the dilutions tested (Fig. 4C) .
As another readout for inhibition, CD16-induced secretion of MIP-1a was evaluated. MIP-1a release induced by rabbit IgG on S2-ICAM-1+Cw3 or S2-ICAM-1+E cells was not inhibited by (Fig. 5A , 5B). We conclude that CD16 signals for chemokine secretion are not inhibited by interaction of inhibitory receptors with peptide-loaded MHC class I molecules on insect cells.
The difference between inhibition by HLA class I on 221 and S2 cells may be due to the different activation signals used. Natural ligands on 221 cells activate natural cytotoxicity, whereas S2 cells coated with rabbit IgG activate NK cells via CD16. To test whether activation of NK cells specifically through CD16 was less sensitive to inhibition than activation through receptor-ligand interactions that promote natural cytotoxicity toward 221 cells, we took advantage of our observation that strong MIP-1a secretion was dependent on CD16 signals, as shown with IgG2a-coated 221 cells (Fig. 5C ). Despite this CD16-dependent enhancement, MIP-1a secretion by a CD158a + NK clone was completely blocked by HLA-Cw15 (Fig. 5C) . Similar results were obtained with 221-Cw7 cells and a CD158b + NK clone (Fig. 5D) . Therefore, the reduced inhibition observed with Drosophila S2 cells compared with that of human 221 cells cannot be explained simply by activation through CD16.
Granule polarization toward ICAM-1-expressing insect cells is blocked by NK cell inhibitory receptors
Although GrzB release was not inhibited by HLA class I on S2 cells (Fig. 4) , the resistance of S2-HLA-C cells from lysis by KIR + NK clones (10) suggests that inhibition occurs at some other activation step. Indeed, analysis of NK cell clones bound to peptide-loaded S2-ICAM-1+Cw3 cells showed complete inhibition of granule polarization (Fig. 6A, 6B ). Likewise, polarization was completely inhibited in CD94-NKG2A + NK cells mixed with peptide-loaded S2-ICAM-1+E cells (Fig. 6A, 6B) . Inhibition of polarization was also observed with a CD158a + b -NKG2A + clone incubated with (Fig. 6B) . These results demonstrate that granule polarization is preferentially inhibited over degranulation and that degranulation can still occur when polarization of the bulk of lytic granules is inhibited.
We then asked whether inhibitory receptors other than KIR and CD94-NKG2A would also block granule polarization. S2-ICAM-1 cells were cotransfected with LLT1, a ligand for inhibitory receptor NKR-P1A (CD161) (20, 21) . Because NKR-P1A is expressed on most NK cells, it was not necessary to isolate NK clones to test for inhibition. IL-2-activated NK cells were mixed with S2 cells expressing either ICAM-1 or ICAM-1 and LLT1 (S2-ICAM-1+LLT1). LFA-1-dependent granule polarization was completely inhibited by LLT1 expression (Fig. 7A) . Furthermore, as observed with S2 cells expressing ICAM-1 and ligands for inhibitory KIR and CD94-NKG2A, CD16-induced degranulation was not inhibited by ICAM-1 and LLT1 coexpression (Fig. 7B) . We conclude that granule polarization is the preferred target for inhibition by different inhibitory receptors.
Expression of ULBP1 on S2 cells is sufficient to induce granule polarization, which is blocked by inhibitory KIR S2 cells expressing ULBP1, which is a ligand for activation receptor NKG2D, triggered polarization of perforin-containing granules in IL-2-activated NK cells (Fig. 8) . We therefore tested whether NKG2D-dependent granule polarization was sensitive to inhibition, just as LFA-1-dependent polarization was. S2 cells coexpressing ULBP1 and HLA-Cw4 (S2-ULBP1+Cw4) were mixed with a CD158a + b -NKG2A + clone. Addition of an HLACw4-specific peptide completely inhibited polarization (Fig. 8A,  8B ). As had been observed with S2-ICAM-1 cells, coengagement of CD16 by addition of rabbit IgG to S2 cells did not overcome inhibition (Fig. 8B) . Therefore, inhibitory receptors are not restricted to inhibition of LFA-1 signals but can also prevent NKG2D-dependent signals for polarization.
We observed that ULBP1 expression on S2 cells was also a strong costimulator of CD16-dependent degranulation (Fig. 8C) , similar to results obtained with S2-ICAM-1 (Fig. 3) . This gave us an opportunity to test inhibition of degranulation induced by the combination of CD16 with NKG2D. A CD158a + b -NKG2A + NK clone was mixed with S2-ULBP-1+Cw4 cells coated with rabbit antiserum in the presence and absence of HLA-Cw4-specific peptide. No inhibition of degranulation was observed (Fig. 8C) . These results confirm, using a different combination of activation signals, that granule polarization is the preferred target for inhibition by inhibitory receptors. 
Discussion
We examined the sensitivity of granule polarization and degranulation by NK cells to inhibition by ITIM-containing receptors. Polarization of granules was always inhibited, irrespective of the inhibitory receptor tested or the cell on which the receptor ligand was expressed. In contrast, inhibition of degranulation, as measured by GrzB release, and of MIP-1a secretion was variable and dependent on the target cell. Inhibition was tested with three different HLA class I specificities on human 221 cells. Drosophila S2 cells were tested after expression of two HLA class I specificities and of the non-MHC ligand for inhibitory receptor NKR-P1A. Using S2 cells expressing defined combinations of ligands of NK cell receptors, it was possible to analyze inhibition of polarization and of degranulation separately. To study HLA class I-specific receptors, it was necessary to isolate and characterize NK cell clones because individual NK cells express different combinations of KIR and CD94-NKG2 receptors (22) . NK cell clones expressing any combination of CD158a, CD158b, and CD94-NKG2A inhibitory receptors were selected for analysis.
Inhibition of degranulation by HLA-C and HLA-E on 221 cells varied among NK clones from very good to incomplete. However, peptide-loaded HLA-C or HLA-E on S2 cells provided partial to very weak inhibition of degranulation. This difference in the inhibitory capacity of human 221 cells versus insect S2 cells was not , which is a ligand of NKR-P1A. We have found that expression of LLT1 on S2 cells is sufficient to block the granule polarization induced by ICAM-1. The Drosophila S2 cell system is well suited to determine the minimal requirements for inhibition, just as it has been to define requirements for activation of NK cells (7) . It is worth noting that inhibitory KIR promotes clustering of activation receptors CD2 and 2B4 at inhibitory NK cell immunological synapses (23) while simultaneously blocking receptor phosphorylation (24) . These results suggested that clustering of signalingincompetent activation receptors at the synapse may serve to strengthen inhibitory signaling. However, coexpression of CD48 with ICAM-1 and HLA-C on S2 cells coated with rabbit IgG did not improve the inhibition of degranulation obtained with ICAM-1 and HLA-C (data not shown). Our data clearly show that granule polarization is more sensitive to inhibition than degranulation is, as it was completely inhibited by expression of either LLT1 or peptide-loaded HLA class I on S2 cells.
As shown with resting NK cells, CD16-induced degranulation can occur in the absence of detectable granule polarization (7) . Likewise, we show here that GrzB release can persist during inhibition of granule polarization. Such unpolarized degranulation may involve fusion of lytic granules that are predocked at the plasma membrane. Even in the absence of stimulation, lytic granules in primary, resting NK cells can be observed at the plasma membrane by microscopy with live cells (25) . The spontaneous release of granzymes by IL-2-activated NK cells may be another example of unpolarized release. This property of NK cells provides an explanation for earlier observations of the lysis of ICAM-1-expressing S2 cells by IL-2-activated NK cells (10) , because the polarization signal transmitted by the ICAM-1-LFA-1 interaction is sufficient to orient the basal granzyme release toward the S2 cells. It is also consistent with the inhibition of lysis of S2-ICAM-1-HLA-C cells by HLA-C-specific KIR + NK clones (10), because inhibition of polarization alone would be sufficient to protect the target cells. The inhibition of polarization shown here in cells that are still degranulating is a direct demonstration that polarization is a preferred target of inhibitory signaling.
Inhibition of degranulation induced by S2 cells was recently examined with resting NK cells (11) . Degranulation, as measured by cell surface LAMP-1 (CD107a), induced by CD16 was partially inhibited by CD94-NKG2A binding to peptide-loaded HLA-E. Stronger inhibition was observed when degranulation was induced by coexpression of ULBP1 and CD48 on S2 cells, which leads to synergistic NK cell activation through receptors NKG2D and 2B4. Inhibition of polarization in resting NK cells could not be investigated, as cloning of NK cells is required to isolate cells with defined inhibitory receptor expression.
The signals that control lytic granule polarization in NK cells are not well known, although specific components of the pathway have been identified (26) (27) (28) . Several receptors in NK cells can contribute to cytolytic granule polarization and cytotoxicity (10, 29, 30) . Using insect cells transfected with individual ligands of NK cell receptors, we have shown that engagement of LFA-1 by ICAM-1 alone is sufficient to induce granule polarization (7, 10) . However, in mouse NK cells, ICAM-1 on beads induces actin cytoskeleton remodeling, and coligation with activation receptor NKG2D is required to induce granule polarization (30) . We report here that expression of ULBP1 on S2 cells is sufficient to induce granule polarization in IL-2-activated human NK cells. Therefore, neither LFA-1 nor NKG2D is necessary, but each one is sufficient to induce polarization of granules in human NK cells, and in both cases polarization is sensitive to inhibition. It will be interesting to investigate how signaling by these two very different receptors converge to induce granule polarization.
The main conclusion is that inhibitory receptors are better equipped to stop granule polarization than to block GrzB and chemokine release. This was shown definitively by observing sustained GrzB and MIP-1a release by NK cells in which granule polarization was inhibited. The evidence obtained for inhibition of NK cells by HLA class I on Drosophila S2 cells is conclusive, because inhibition is dependent on addition of HLA class I-specific peptides. Persistent degranulation during inhibition of polarization in IL-2-activated NK cells suggests that it may occur in high inflammatory conditions. Prevention of NK cell cytotoxicity would be better achieved through inhibition of degranulation rather than polarization. However, the possibility of releasing the block in degranulation while maintaining inhibition of polarization endows NK cells with the potential to provide bystander killing while still refraining from direct attacks on MHC class I-positive cells.
